The impact of HLA unidirectional mismatches on the outcome of myeloablative hematopoietic stem cell transplantation with unrelated donors

Blood

Volumn 121, Issue 23, 2013, Pages 4800-4806

  Hurley, Carolyn Katovich ^a   Woolfrey, Ann ^b   Wang, Tao ^c   Haagenson, Michael ^d   Umejiego, John ^d   Aljurf, Mahmoud ^e   Askar, Medhat ^f   Battiwalla, Minoo ^g   Dehn, Jason ^h   Horan, John ⁱ   Oudshoorn, Machteld ^j   Pidala, Joseph ^k   Saber, Wael ^c   Turner, Victoria ^l   Lee, Stephanie J ^b   Spellman, Stephen R ^d  

^a GEORGETOWN UNIVERSITY   (United States)

^b USA   (United States)

^c MEDICAL COLLEGE OF WISCONSIN   (United States)

^d Statistical Center for International Blood and Marrow Transplant Research   (United States)

^e KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^f CLEVELAND CLINIC LERNER COLLEGE OF MEDICINE   (United States)

^g NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^h NATIONAL MARROW DONOR PROGRAM   (United States)

ⁱ EMORY UNIVERSITY   (United States)

^j LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^k H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^l ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; HLA A ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; HLA DRB1 ANTIGEN; TACROLIMUS; HLA ANTIGEN; MYELOABLATIVE AGENT;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE MYELOID LEUKEMIA; ADOLESCENT; ADULT; AGE; AGED; ARTICLE; CAUSE OF DEATH; CHILD; CHRONIC GRAFT VERSUS HOST DISEASE; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; DISEASE FREE SURVIVAL; ENGRAFTMENT; FEMALE; FOLLOW UP; GRAFT FAILURE; GRAFT RECIPIENT; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY; HLA MATCHING; HLA MISMATCH; HLA SYSTEM; HOMOZYGOSITY; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; MYELOABLATIVE CONDITIONING; MYELODYSPLASTIC SYNDROME; NEUTROPHIL; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRESCHOOL CHILD; PRIORITY JOURNAL; RACE; RELAPSE; SCHOOL CHILD; SURVIVAL RATE; UNRELATED DONORS; YOUNG ADULT; HEMATOLOGIC DISEASE; IMMUNOSUPPRESSIVE TREATMENT; METABOLISM; NEWBORN; PROGNOSIS; RISK FACTOR; STATISTICS;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; GRAFT VS HOST DISEASE; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY; HLA ANTIGENS; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; MYELOABLATIVE AGONISTS; PROGNOSIS; RISK FACTORS; SURVIVAL RATE; TRANSPLANTATION CONDITIONING; UNRELATED DONORS; YOUNG ADULT;

MLCS; MLOWN;

EID: 84881050569     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2013-01-480343     Document Type: Article

References (18)

1. Lee SJ, Klein J, Haagenson M, et al. High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation. Blood. 2007;110(13): 4576-4583.
2. Woolfrey A, Klein JP, Haagenson M, et al. HLA-C antigen mismatch is associated with worse outcome in unrelated donor peripheral blood stem cell transplantation. Biol Blood Marrow Transplant. 2011;17(6):885-892.
3. Spellman SR, Eapen M, Logan BR, et al; National Marrow Donor Program; Center for International Blood and Marrow Transplant Research. A perspective on the selection of unrelated donors and cord blood units for transplantation. Blood. 2012;120(2):259-265.
4. Petersdorf EW, Hansen JA, Martin PJ, et al. Major-histocompatibility-complex class I alleles and antigens in hematopoietic-cell transplantation. N Engl J Med. 2001;345(25): 1794-1800.
5. Farag SS, Bacigalupo A, Eapen M, et al; KIR Study Group, Center for International Blood and Marrow Transplantation Research. The effect of KIR ligand incompatibility on the outcome of unrelated donor transplantation: a report from the center for international blood and marrow transplant research, the European blood and marrow transplant registry, and the Dutch registry. Biol Blood Marrow Transplant. 2006;12(8): 876-884.
6. Spellman S, Setterholm M, Maiers M, et al. Advances in the selection of HLA-compatible donors: refinements in HLA typing and matching over the first 20 years of the National Marrow Donor Program Registry. Biol Blood Marrow Transplant. 2008;14(suppl 9):37-44.
7. Glucksberg H, Storb R, Fefer A, et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation. 1974;18(4): 295-304.
8. Shulman HM, Sullivan KM, Weiden PL, et al. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med. 1980;69(2):204-217.
9. Ballen KK, Koreth J, Chen YB, Dey BR, Spitzer TR. Selection of optimal alternative graft source: mismatched unrelated donor, umbilical cord blood, or haploidentical transplant. Blood. 2012; 119(9):1972-1980.
10. Fuchs E, O’Donnell PV, Brunstein CG. Alternative transplant donor sources: is there any consensus? Curr Opin Oncol. 2013;25(2): 173-179.
11. Geiger TL, Woodard P, Tong X, et al. Human leucocyte antigen alloimmunization after bone marrow transplantation: an association with chronic myelogenous leukaemia. Br J Haematol. 2002;117(3):634-641.
12. Stevens CE, Carrier C, Carpenter C, Sung D, Scaradavou A. HLA mismatch direction in cord blood transplantation: impact on outcome and implications for cord blood unit selection. Blood. 2011;118(14):3969-3978.
13. Kanda J, Atsuta Y, Wake A, et al; HLA Working Group of the Japan Society for Hematopoietic Cell Transplantation. Impact of the direction of HLA mismatch on transplantation outcomes in single unrelated cord blood transplantation. Biol Blood Marrow Transplant. 2013;19(2):247-254.
14. Spellman S, Bray R, Rosen-Bronson S, et al. The detection of donor-directed, HLA-specific alloantibodies in recipients of unrelated hematopoietic cell transplantation is predictive of graft failure. Blood. 2010;115(13):2704-2708.
15. Ciurea SO, Thall PF, Wang X, et al. Donor-specific anti-HLA Abs and graft failure in matched unrelated donor hematopoietic stem cell transplantation. Blood. 2011;118(22):5957-5964.
16. Ottinger HD, Rebmann V, Pfeiffer KA, et al. Positive serum crossmatch as predictor for graft failure in HLA-mismatched allogeneic blood stem cell transplantation. Transplantation. 2002;73(8): 1280-1285.
17. Takanashi M, Atsuta Y, Fujiwara K, et al. The impact of anti-HLA antibodies on unrelated cord blood transplantations. Blood. 2010;116(15): 2839-2846.
18. Cutler C, Kim HT, Sun L, et al. Donor-specific anti-HLA antibodies predict outcome in double umbilical cord blood transplantation. Blood. 2011; 118(25):6691-6697.